Moderna, Inc. (MRNA) Q2 2024 Earnings Results

Moderna Misses on EPS, Stock Down 21.01%

Moderna's disappointing EPS result reflects ongoing challenges in the market, contributing to a significant drop in stock price. Investors reacted negatively, likely due to uncertainty about the company's future performance and lack of guidance. The 21.01% decline indicates a loss of confidence among investors following the earnings report.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-3.33	N/A	+3.95%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Defensive

Overall, management expressed concerns about market conditions impacting performance. They indicated a focus on adapting strategies to navigate these challenges.

Management emphasized the ongoing challenges in the current market environment.

They highlighted the need for strategic adjustments moving forward.

Moderna Misses on EPS, Stock Down 21.01%

Key numbers

Management commentary

Moderna, Inc.

More earnings this week

Moderna Misses on EPS, Stock Down 21.01%

Key numbers

Management commentary